6BW-70609-38189
2 vaccinations
5 coded responses
22 check-ins
5 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 493 / MI
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities2 call case(s)
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-13
Survey response — day 7, dose 1MedDRA: Diarrhoea, Erythema, Injection site erythema, Injection site pruritus — Feeling: Good · Diarrhea · Be unable to workFree text: I have not received a check in for several days. On the 4th day after injection I was itchy along the incision , had redness as well as diarrhea.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Joint pains, Muscle or body aches, NauseaAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-10
-
2021-02-17
Survey response — day 21, dose 2MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to workFree text: Headache fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-03
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-04-30
- 2021-07-28
- 2021-07-30
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Endometrial ablation, Uterine dilation and curettage, Vaginal haemorrhage — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Vaginal bleeding · Healthcare visit (other): Needed iron infusion, D & C and ablationMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-01-31
-
2022-01-31
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-06 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-06 | priority 2/3 | |
| 2021-01-13 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-13 | priority 2/3 | |
| 2021-02-24 | Unsuccessful | |
| 2022-01-29 | Successful 2022-01-31 |
Participant prefers to complete VAERS report online |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): I have not received a check in for several days. On the 4th day after injection I was itchy along the incision , had redness as well as diarrhea.
Release 4 — day 21, dose 2
Symptoms: Headache fatigue
Release 4 — day 28, dose 2
Symptoms: Migraine
Release 5 — day 35, dose 2
Symptoms: Fatigue
Release 11 — 12 months, dose 2
Symptoms: Vaginal bleeding
Healthcare visit (other): Needed iron infusion, D & C and ablation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Endometrial ablation | · | · | ✓ |
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
| SRO | Diarrhoea | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release